Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC Trial) A Randomized Study

International Journal of Gynecological Cancer

Volumn 19, Issue 8, 2009, Pages 1465-

  Barton, Desmond P J ^a   Naik, Raj ^b   Herod, Jonathan ^c  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b Northern Gynaecological Oncology Centre   (United Kingdom)

^c LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMETRIUM CANCER; HUMAN; LAPAROSCOPIC SURGERY; LETTER; LYMPH NODE METASTASIS; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; PELVIC NEOPLASMS; PROGNOSIS; TREATMENT OUTCOME;

EID: 73349114604     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181b89f95     Document Type: Letter

References (3)

1. Panici PB, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: Randomized Clinical Trial. J Natl Cancer Inst. 2008;100:1707-1716.
2. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. Cancer. 1987;60: 2035-2041.
3. ASTEC Study Group: Kitchener H, Swart AM, Qian Q, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised trial. Lancet. 2009:373:125-136.